Artivion (AORT) Other Operating Expenses (2010 - 2025)

Artivion (AORT) posted Other Operating Expenses of $3.5 million for Q4 2025, little changed on a QoQ basis from $3.5 million in Q3 2025.

Artivion (AORT) Other Operating Expenses (2010 - 2025) Analysis & Trends

Artivion's Other Operating Expenses history runs 6 years deep, the most recent figure standing at $3.5 million for Q4 2025.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $3.5 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $7.0 million (changed N/A YoY) and the FY2025 annual result came in at $7.0 million, changed N/A from the prior year.
  • Other Operating Expenses was $3.5 million for Q4 2025 at Artivion, roughly flat from $3.5 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $15.9 million in Q3 2021 and bottomed at -$44.3 million in Q2 2021.
  • A 3-year average of -$8.3 million and a median of $3.5 million in 2025 frame the typical range for Other Operating Expenses.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Artivion 1.25 Bn 1.19 Bn 75.45 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.50 Mn
Sep 30, 2025 3.50 Mn
Jun 30, 2023 14.25 Mn
Sep 30, 2021 15.92 Mn
Jun 30, 2021 -44.34 Mn
Mar 31, 2021 -42.35 Mn
Mar 31, 2016 7.92 Mn
Jun 30, 2012 10.27 Mn
Sep 30, 2010 3.51 Mn